|
|
||||||||
Radiology, Vol 196, 857-862, Copyright © 1995 by Radiological Society of North America
ARTICLES |
H Nakahara, S Noguchi, N Murakami, M Morita, M Tamaru, T Ohnishi, H Hoshi, S Jinnouchi, S Nagamachi and S Futami
Noguchi Thyroid Clinic, Oita, Japan.
PURPOSE: To establish the most effective radiation dose for treatment of Graves ophthalmopathy (GO). MATERIALS AND METHODS: A combination of 10 Gy (n = 15) or 24 Gy (n = 16) of radiation and corticosteroids was used to treat 31 patients with GO. Magnetic resonance (MR) images obtained before treatment showed swollen extraocular muscles with prolonged T2 relaxation times in all patients. RESULTS: Before therapy, T2 relaxation time of extraocular muscle was 79.6 msec (95% confidence interval, 76.3, 82.9) in the 24-Gy group and 77.4 msec (95% confidence interval, 74.6, 80.1) in the 10-Gy group (P = .32). After therapy, T2 relaxation time was 62.8 msec (95% confidence interval, 61.2, 64.4) in the 24-Gy group and 68.9 msec (95% confidence interval, 66.8, 71.1) in the 10-Gy group. In the 24-Gy group, there was a significant decrease in T2 relaxation times (P = .001) and clinical response to initial treatment was better. At 1- and 3-month follow-up, the resistance rate was lower in the 24-Gy group. CONCLUSION: In treatment of GO, 24 Gy of radiation is a more effective dose than 10 Gy when combined with systemic corticosteroids.
This article has been cited by other articles:
![]() |
L. Bartalena, L. Baldeschi, A. Dickinson, A. Eckstein, P. Kendall-Taylor, C. Marcocci, M. Mourits, P. Perros, K. Boboridis, A. Boschi, et al. Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO Eur. J. Endocrinol., March 1, 2008; 158(3): 273 - 285. [Full Text] [PDF] |
||||
![]() |
M Ott, N Breiter, C F Albrecht, O Pradier, C F Hess, and H Schmidberger Can contrast enhanced MRI predict the response of Graves' ophthalmopathy to orbital radiotherapy? Br. J. Radiol., June 1, 2002; 75(894): 514 - 517. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Bartalena, A. Pinchera, and C. Marcocci Management of Graves' Ophthalmopathy: Reality and Perspectives Endocr. Rev., April 1, 2000; 21(2): 168 - 199. [Abstract] [Full Text] |
||||
![]() |
G. J. Kahaly, H.-P. Rösler, S. Pitz, and G. Hommel Low- Versus High-Dose Radiotherapy for Graves' Ophthalmopathy: A Randomized, Single Blind Trial J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 102 - 108. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |